|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.36 USD | -1.41% |
|
-3.38% | +2.25% |
| 01-20 | Mizuho Adjusts Price Target on Henry Schein to $81 From $74, Maintains Neutral Rating | MT |
| 01-18 | Tetratherix Secures Distribution Deal With Healthcare Product Distributor; Shares Up 3% | MT |
| Capitalization | 9.24B 7.86B 7.28B 6.81B 12.69B 849B 13.45B 83.23B 33.04B 401B 34.64B 33.93B 1,458B | P/E ratio 2025 * |
23.1x | P/E ratio 2026 * | 18.6x |
|---|---|---|---|---|---|
| Enterprise value | 12.19B 10.36B 9.61B 8.98B 16.73B 1,120B 17.74B 110B 43.58B 529B 45.69B 44.76B 1,923B | EV / Sales 2025 * |
0.93x | EV / Sales 2026 * | 0.87x |
| Free-Float |
99.51% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Henry Schein, Inc.
| 1 day | -1.47% | ||
| 1 week | -3.38% | ||
| Current month | +2.25% | ||
| 1 month | +1.02% | ||
| 3 months | +21.53% | ||
| 6 months | +4.16% | ||
| Current year | +2.25% |
| 1 week | 76.96 |  | 79.8 |
| 1 month | 74.07 | | 80.1 |
| Current year | 74.07 | | 80.1 |
| 1 year | 60.56 | | 82.49 |
| 3 years | 60.01 | | 89.72 |
| 5 years | 60.01 | | 92.68 |
| 10 years | 41.85 | | 93.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stanley Bergman
CEO | Chief Executive Officer | 76 | 1988-12-31 |
Ronald South
DFI | Director of Finance/CFO | 64 | 2022-04-28 |
| Chief Tech/Sci/R&D Officer | 63 | 2018-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stanley Bergman
CHM | Chairman | 76 | 1988-12-31 |
Philip Laskaway
BRD | Director/Board Member | 83 | 2002-01-31 |
Bradley Sheares
BRD | Director/Board Member | 69 | 2010-01-19 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | 0.00% | 1.54% | 2 M€ | |
| 0.00% | 1.07% | 4 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.41% | -3.38% | +3.38% | -4.92% | 9.24B | |
| +1.56% | -0.92% | - | - | 1.85B | |
| +1.73% | +0.26% | +27.40% | +7.91% | 1.56B | |
| +0.73% | -1.40% | -3.15% | -13.42% | 1.09B | |
| +4.80% | +2.87% | +176.68% | +63.06% | 1.03B | |
| +1.64% | +1.81% | +23.80% | - | 816M | |
| +0.13% | -0.88% | -3.43% | +30.65% | 428M | |
| +0.29% | -1.16% | +4.21% | +36.75% | 238M | |
| +0.04% | +0.04% | +24.20% | +54.52% | 235M | |
| Average | +1.05% | +0.18% | +31.64% | +24.93% | 1.83B | |
| Weighted average by Cap. | -0.05% | +0.33% | +18.99% | +3.78% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 13.08B 11.13B 10.31B 9.64B 17.97B 1,202B 19.04B 118B 46.8B 568B 49.06B 48.06B 2,065B | 13.53B 11.5B 10.66B 9.96B 18.57B 1,243B 19.69B 122B 48.38B 587B 50.72B 49.68B 2,134B |
| Net income | 416M 354M 328M 306M 571M 38.22B 605M 3.75B 1.49B 18.04B 1.56B 1.53B 65.64B | 492M 419M 388M 363M 676M 45.21B 716M 4.43B 1.76B 21.35B 1.85B 1.81B 77.65B |
| Net Debt | 2.95B 2.51B 2.32B 2.17B 4.05B 271B 4.29B 26.55B 10.54B 128B 11.05B 10.83B 465B | 2.57B 2.18B 2.02B 1.89B 3.53B 236B 3.74B 23.13B 9.18B 111B 9.63B 9.43B 405B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-23 | 77.31 $ | -1.48% | 561,615 |
| 26-01-22 | 78.47 $ | -0.60% | 944,496 |
| 26-01-21 | 78.94 $ | +1.56% | 924,105 |
| 26-01-20 | 77.73 $ | -2.81% | 1,498,618 |
| 26-01-16 | 79.98 $ | +2.43% | 1,925,410 |
Delayed Quote Nasdaq, January 23, 2026 at 03:24 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HSIC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition